Clinical Trials Logo

Filter by:
NCT ID: NCT02471586 Completed - Clinical trials for Coronary Artery Disease

OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiography to Guide Coronary Stent Implantation

ILUMIEN III
Start date: May 2015
Phase: N/A
Study type: Interventional

The objective of this clinical investigation is to demonstrate the safety and efficacy of an OCT guided strategy for stent implantation

NCT ID: NCT02471144 Completed - Clinical trials for Chronic Severe Plaque-type Psoriasis

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Start date: September 29, 2015
Phase: Phase 3
Study type: Interventional

This was a multicenter, randomized, double-blind, placebo- and active-controlled (etanercept in single blinded arm) study in pediatric subjects aged 6 years to less than 18 years with severe chronic plaque psoriasis. Approximately 160 subjects aged 6 years to <18 years were enrolled, of which at least 30 were 6 years to <12 years old. Subjects were enrolled at approximately 70 study sites worldwide.

NCT ID: NCT02470585 Terminated - Ovarian Cancer Clinical Trials

Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

VELIA
Start date: June 29, 2015
Phase: Phase 3
Study type: Interventional

The primary objective of the study was to evaluate whether progression-free survival (PFS) was prolonged with the addition of veliparib to standard platinum-based chemotherapy (carboplatin/paclitaxel [C/P]) and continued as maintenance therapy compared with chemotherapy alone.

NCT ID: NCT02470052 Terminated - Emphysema Clinical Trials

A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema

Start date: August 2015
Phase: N/A
Study type: Interventional

This is a multicenter,single-arm,open-label study designed to evaluate improvement of lung function and safety after treatment with OL-BF-001 for severe emphysema. OL-BF-001 consists of a bronchial valve, deployment catheter, loader and airway sizing kit. A bronchial valve is a small, umbrella-shaped, one-way valve that is placed inside the airways of one lung. It is used to redirect air from the less healthy to the more healthy parts of the lung. This helps to reduce over-inflation and may improve overall lung function and quality of life for people living with emphysema.

NCT ID: NCT02469688 Completed - Cedar Pollinosis Clinical Trials

A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy

Start date: June 18, 2015
Phase: Phase 1
Study type: Interventional

Examine safety and immunological response for ASP4070 when vaccinated in patients with pollen allergy

NCT ID: NCT02468674 Completed - Sarcopenia Clinical Trials

A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study

Start date: July 22, 2015
Phase: Phase 2
Study type: Interventional

This extension study was a 24-week off-drug follow-up of the core CBYM338E2202 (NCT ) study and the main objective was to determine the long-term durability of bimagrumab (BYM338) effect after a 6-month treatment period.

NCT ID: NCT02468661 Terminated - Clinical trials for Non-Small Cell Lung Cancer

A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification

Start date: September 23, 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study was to determine the maximum tolerated dose (MTD) or recommended phase II dose (RP2D) of INC280 in combination with erlotinib in the Phase Ib of this study, and to assess the anti-tumor activity and safety of INC280 alone, and in combination with erlotinib, versus platinum with pemetrexed in the Phase II of this study, in adult patients with EGFR mutated, cMET amplified, advanced/metastatic non-small cell lung cancer with acquired resistance to prior EGFR TKI.

NCT ID: NCT02468466 Completed - Suicide Clinical Trials

A Community-based Depression Screening Intervention for Middle-aged Suicide

Start date: January 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effectiveness of a community-based depression-screening program for suicide prevention among middle-aged adults, the investigators conducted a quasi-experimental intervention study, using a parallel cluster design with communities at municipal level as the unit of allocation and individuals as the unit of analysis.

NCT ID: NCT02468232 Completed - Clinical trials for Heart Failure With Reduced Ejection Fraction (HF-rEF)

Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction

PARALLEL-HF
Start date: June 15, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study was to assess the effect of LCZ696 at a target dose of 200 mg b.i.d. compared to enalapril 10 mg b.i.d., in addition to the background heart failure (HF) treatment, on delaying time to first occurrence of either cardiovascular (CV) death or HF hospitalization events in Japanese patients with stable chronic heart failure (CHF), New York Heart Association (NYHA) classes II-IV and reduced ejection fraction (left ventricular ejection fraction (LVEF) ≤ 35%).

NCT ID: NCT02468193 Completed - Cushing's Syndrome Clinical Trials

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Start date: September 24, 2015
Phase: Phase 2
Study type: Interventional

The study aim was to investigate the efficacy and safety of Osilodrostat in patients with Cushing's syndrome due to causes other than Cushing's disease in Japan.